Acute Lymphoblastic Leukemia in Children and Adolescents

No abstract is available for this paper.

• Publication year

  2018

• Venue

  The EBMT Handbook

• Publication date

  2018-12-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-3-030-02278-5_72
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Tisagenlecleucel in Children and Young Adults with B‐Cell Lymphoblastic Leukemia

  2018cited by this paper
• Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia

  2017cited by this paper
• Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic Malignancies.

  2017cited by this paper
• Myeloablative Conditioning for First Allogeneic Hematopoietic Stem Cell Transplantation in Children with ALL: Total Body Irradiation or Chemotherapy? - a Multicenter EBMT-PDWP Study

  2017cited by this paper
• Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion.

  2017cited by this paper
• Feasibility and Outcome of Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant High-Dose Cyclophosphamide for Children and Adolescents with Hematologic Malignancies: An AIEOP-GITMO Retrospective Multicenter Study.

  2016cited by this paper
• New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia

  2016cited by this paper
• Favorable outcome of hematopoietic stem cell transplantation using a targeted once-daily intravenous busulfan-fludarabine-etoposide regimen in pediatric and infant acute lymphoblastic leukemia patients.

  2015cited by this paper
• Treosulfan-based conditioning regimens for allogeneic HSCT in children with acute lymphoblastic leukaemia

  2015cited by this paper
• Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial.

  2015cited by this paper
• Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trial.

  2015cited by this paper
• Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research.

  2015cited by this paper
• Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

  2014cited by this paper
• Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen

  2014cited by this paper
• Hematopoietic stem cell transplantation for children with high-risk acute lymphoblastic leukemia in first complete remission: a report from the AIEOP registry

  2013cited by this paper
• Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia - long-term results of trial ALL-REZ BFM P95/96.

  2013cited by this paper
• Impact of pretransplant minimal residual disease after cord blood transplantation for childhood acute lymphoblastic leukemia in remission: an Eurocord, PDWP–EBMT analysis

  2012cited by this paper
• Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation.

  2012cited by this paper
• Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcomes after unrelated donor transplantation for childhood acute lymphoblastic leukemia.

  2012cited by this paper
• Comparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia.

  2012cited by this paper
• Outcomes after induction failure in childhood acute lymphoblastic leukemia.

  2012cited by this paper
• High-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant?

  2011cited by this paper
• Treosulfan-based preparative regimens for allo-HSCT in childhood hematological malignancies: a retrospective study on behalf of the EBMT pediatric diseases working party

  2011cited by this paper
• Outcome of children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: a retrospective analysis of the ALL-REZ BFM Study Group.

  2011cited by this paper
• Very early/early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatment

  2011cited by this paper
• Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study.

  2011cited by this paper
• Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia

  2011cited by this paper
• Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study.

  2010cited by this paper
• Philadelphia chromosome-positive acute lymphoblastic leukemia in children: new and emerging treatment options

  2010cited by this paper
• Pediatric related and unrelated cord blood transplantation for malignant diseases

  2009cited by this paper
• Hematopoietic cell transplantation for children with acute lymphoblastic leukemia in second complete remission: similar outcomes in recipients of unrelated marrow and umbilical cord blood versus marrow from HLA matched sibling donors.

  2009cited by this paper
• Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.

  2009cited by this paper
• Haploidentical SCT in children: an update and future perspectives

  2008cited by this paper
• Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial.

  2000cited by this paper
• Clinical Trials and Observations

  year unknowncited by this paper

• Protein Arginine Methyltransferases (PRMTs): Orchestrators of Cancer Pathogenesis, Immunotherapy Dynamics, and Drug Resistance.

  2024cites this paper
• Lipid have a direct effect on multiple myeloma: a Mendelian randomization study

  2024cites this paper
• Identification of a novel MEF2C::SS18L1 fusion in childhood acute B-lymphoblastic leukemia

  2024cites this paper
• Evolving Horizons in Pediatric Leukemia: Novel Insights, Challenges, and the Journey Ahead

  2024influential citation
• Cancer cell contamination and decontamination methods for ovaries and testes: special focus on prepubertal gonads with a view to safe fertility restoration.

  2023cites this paper
• Treatment outcomes in childhood acute lymphoblastic leukemia: 40-year experience from a single tertiary center in Thailand

  2023cites this paper
• ĐẶC ĐIỂM CỦA CHỈ SỐ BẠCH CẦU HẠT CHƯA TRƯỜNG THÀNH (IG) TRÊN CÔNG THỨC MÁU Ở TRẺ BẠCH CẦU CẤP TẠI BỆNH VIỆN NHI ĐỒNG 1

  2023cites this paper
• Allergic Reactions to E. coli Asparaginase are Associated with Decreased Asparaginase Activity in an Indonesian Pediatric Population with ALL

  2023cites this paper
• Comparative assessment of anti-cancer drugs against NUDT15 variants to prevent leucopenia side effect in leukemia patients

  2023cites this paper
• RUNX1 colludes with NOTCH1 to reprogram chromatin in T cell acute lymphoblastic leukemia

  2023cites this paper
• A New Model for Blood Cancer Classification Based on Deep Learning Techniques

  2023cites this paper
• TCF3 gene rearrangements in pediatric B‐cell acute lymphoblastic leukemia—A single center experience

  2023cites this paper
• Đánh giá hiệu quả điều trị của tế bào CAR-T trên chuột mang tế bào u lympho dòng B thể lan tỏa

  2023influential citation
• Differences in Parathyroid Hormone-Related Peptide and Serum Electrolytes in Acute Leukemia Patients

  2023cites this paper
• Quality of Life among Adolescents with Leukemia

  2023cites this paper
• Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication

  2023cites this paper
• Autophagy: A challengeable paradox in cancer treatment

  2023cites this paper
• Genetic Polymorphism of Thiopurine S-Methyltransferase in Children with Acute Lymphoblastic Leukemia

  2023influential citation
• Association of CDKN2A/B mutations, PD-1, and PD-L1 with the risk of acute lymphoblastic leukemia in children

  2023cites this paper
• Molecular characterization of TCF3::PBX1 chromosomal breakpoints in acute lymphoblastic leukemia and their use for measurable residual disease assessment

  2023influential citation
• Identification of lncRNAs associated with the progression of acute lymphoblastic leukemia using a competing endogenous RNAs network

  2023cites this paper
• Effect of Family-Centered Empowerment Model on Knowledge and Caring Performance of Mothers of Children with Leukemia: A Randomized Clinical Trial

  2023cites this paper
• Quality of life of adolescent and adult survivors of childhood cancer in Europe—A systematic review

  2023cites this paper
• Augmenter of liver regeneration promotes drug resistance of acute lymphoblastic leukemia through the alteration of mitochondrial functions and the inhibition of the mitochondrial apoptosis pathway

  2023cites this paper
• The anti-cancer impact of Genistein against Acute Lymphoblastic Leukemia by controlling DICER and AGO2 involved in cytoplasmic microRNAs biogenesis – a possible new clue to mode of action of Genistein

  2023cites this paper
• A new insight updates in diagnosis and management of acute lymphoblastic leukemia, cytogenetics, immunophenotyping, and proteomic profile

  2023cites this paper
• Rituximab plus multiagent chemotherapy for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective phase II study

  2023cites this paper
• Immunotherapy in hematologic malignancies: achievements, challenges and future prospects

  2023cites this paper
• Effect of methylprednisolone on the morphology of acute lymphoblastic leukemia cell line in vitro model by Atomic Force Microscopy

  2023cites this paper
• Survival rate of children acute lymphoblastic leukemia at the end of therapy protocol with minimal residual disease (MRD) in Prof I G.N.G. Ngoerah General Hospital Denpasar

  2023influential citation
• A novel prognostic nomogram for adult acute lymphoblastic leukemia: a comprehensive analysis of 321 patients

  2023cites this paper
• Flow cytometric assessment of leukemia-associated monocytes in childhood B-cell acute lymphoblastic leukemia outcome

  2023cites this paper
• Clinical applicability of short form of Bruininks-Oseretsky Test of Motor Proficiency Second Edition in patients after treatment of acute lymphoblastic leukemia

  2023cites this paper
• The Relationship between Gene Polymorphisms od the XRCC1 and TP53 with the Gender of Children with Acute Leukemia

  2023cites this paper
• Azacitidine in Combination with Venetoclax Maintenance Post-allogeneic Hematopoietic Stem Cell Transplantation in T Cell Acute Lymphoblastic Leukemia

  2023cites this paper
• Precursor B-cell acute lymphoblastic leukemia presenting with isolated skin relapse: a pediatric case report

  2023cites this paper
• Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition

  2023cites this paper
• Prognostic value of cross‐lineage expression of the myeloid‐associated antigens CD13 and CD33 in adult B‐lymphoblastic leukemia: A large real‐world study of 1005 patients

  2023cites this paper
• The emerging scenario of immunotherapy for T-cell Acute Lymphoblastic Leukemia: advances, challenges and future perspectives

  2023cites this paper
• Hypertriglyceridemia associated with anticancer therapy based on asparaginase and steroids: a retrospective single center study of children with acute lymphoblastic leukemia and lymphoblastic lymphoma

  2023cites this paper
• Application of Visual Distraction Diversion in An.G with Acute Lymphoblastic Leukemia (ALL) in Reducing Acute Pain Levels at the RSPAD Gatot Soebroto Hospital

  2023cites this paper
• LEVEL OF 25 (OH) COLECALCIFEROL (VIT-D) IN ACUTE LYMPHOBLASTIC LEUKEMIA: A META ANALYSIS

  2022cites this paper
• EFFECTS OF MALNUTRITION ON THE PROGNOSIS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

  2022influential citation
• Inhibition of Skp2 enhances doxorubicin‐induced cell death in B cell precursor acute lymphoblastic leukemia

  2022cites this paper
• Efficacy and Safety of Levofloxacin Prophylaxis During Induction Therapy for Childhood Acute Lymphoblastic Leukemia

  2022cites this paper
• Utilization of CRISPR-Mediated Tools for Studying Functional Genomics in Hematological Malignancies: An Overview on the Current Perspectives, Challenges, and Clinical Implications

  2022cites this paper
• Identification of new ETV6 modulators through a high-throughput functional screening

  2022cites this paper
• PaDef (Persea americana var. drymifolia), a Plant Antimicrobial Peptide, Triggers Apoptosis, and Induces Global Epigenetic Modifications on Histone 3 in an Acute Lymphoid Leukemia Cell Line

  2022cites this paper
• Wilms' tumor 1 peptide‐loaded dendritic cell vaccination in patients with relapsed or refractory acute leukemia

  2022cites this paper
• Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping

  2022cites this paper
• Safety and Efficacy of Alendronate to Treat Osteopenia in Children During Therapy for Acute Lymphoblastic Leukemia: A Retrospective Cohort Study of Sequential Outcomes

  2022cites this paper
• CASPorter: A Novel Inducible Human CASP1/NALP3/ASC Inflammasome Biosensor

  2022cites this paper
• Chimeric Antigen Receptor T-Cell Therapy in Paediatric B-Cell Precursor Acute Lymphoblastic Leukaemia: Curative Treatment Option or Bridge to Transplant?

  2022cites this paper
• Targeting the lncRNA DUXAP8/miR-29a/PIK3CA Network Restores Doxorubicin Chemosensitivity via PI3K-AKT-mTOR Signaling and Synergizes With Inotuzumab Ozogamicin in Chemotherapy-Resistant B-Cell Acute Lymphoblastic Leukemia

  2022cites this paper
• An efficient CNN-based Automated Leukemia diagnosis Using microscopic blood smear images and Subtypes Classification

  2022cites this paper
• Augmented Berlin-Frankfurt-Munster versus GRAALL-2003 in young adults with Philadelphia-negative, B-cell acute lymphoblastic leukemia: A single-center experience

  2022cites this paper
• Current Status of Novel Agents for the Treatment of B Cell Malignancies: What’s Coming Next?

  2022cites this paper
• Multi-omics characterization of autophagy-related molecular features for therapeutic targeting of autophagy

  2022cites this paper
• Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes

  2022cites this paper
• Predicting clinical response to everolimus in ER+ breast cancers using machine-learning

  2022cites this paper
• Status Vitamin D pada Anak dengan Leukemia Akut

  2022cites this paper
• Cytogenetics and Molecular Genetics in Pediatric Acute Lymphoblastic Leukemia (ALL) and Its Correlation with Induction Outcomes

  2022cites this paper
• Persistently high incidence rates of childhood acute leukemias from 2010 to 2017 in Mexico City: A population study from the MIGICCL

  2022cites this paper
• Dual inhibition of EZH1/2 induces cell cycle arrest of B cell acute lymphoblastic leukemia cells through upregulation of CDKN1C and TP53INP1

  2022cites this paper
• Bilateral parotid swelling: An unmissable diagnosis

  2022cites this paper
• Correlation of preferentially expressed antigen of melanoma (PRAME) gene expression with clinical characteristics in acute leukemia patients

  2022cites this paper
• Clinicolaboratory Characteristics and Outcome of Pediatric Acute Lymphoblastic Leukemia in a Resource-Limited Setting: A Study from South Egypt

  2022cites this paper
• Targeting H3K4 methylation as a novel therapeutic strategy against tumor infiltration and nuclear changes of acute lymphoblastic leukemia cells

  2022cites this paper
• Immunoglobulin Heavy Chain High-Throughput Sequencing in Pediatric B-Precursor Acute Lymphoblastic Leukemia: Is the Clonality of the Disease at Diagnosis Related to Its Prognosis?

  2022influential citation
• Relationship between Bax and Bcl-2 Protein Expression and Outcome of Induction Phase Chemotherapy in Pediatric Acute Lymphoblastic Leukemia

  2022cites this paper
• Evaluation of serum level of lymphoid enhancer-binding factor-1 and its relation with clinico-hematological and prognostic parameters in pediatric patients with acute lymphoblastic leukemia

  2022cites this paper
• Etiology and Outcome of Seizures in Children during Induction Remission Chemotherapy for Acute Lymphoblastic Leukaemia

  2022cites this paper
• Efficacy and Safety of Piperacillin-Tazobactam and Cefepime as Empirical Therapy for Febrile Neutropenic Children with Acute Lymphoblastic Leukaemia (ALL)

  2022cites this paper
• The Role of Lamins in the Nucleoplasmic Reticulum, a Pleiomorphic Organelle That Enhances Nucleo-Cytoplasmic Interplay

  2022cites this paper
• Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades

  2022cites this paper
• Short-term effect of growth hormone treatment in childhood leukemia survivors with growth hormone deficiency

  2022cites this paper
• JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies

  2022influential citation
• A New and Cost-Effective Approach to Risk Stratification for Children with Precursor B-Cell Acute Lymphoblastic Leukemia Based on Competing Outcomes

  2022cites this paper
• Polo-like Kinase 4: the Variation During Therapy and its Relation to Treatment Response and Prognostic Risk Stratification in Childhood Acute Lymphoblastic Leukemia Patients

  2022cites this paper
• Cytogenetic Risk Stratification of B-Acute Lymphoblastic Leukemia and Its Correlation with Other Prognostic Factors

  2022cites this paper
• Pulmonary function is a strong predictor of 2‐year overall survival and non‐relapse mortality after allogenic hematopoietic cell transplantation

  2022cites this paper
• A Deep Learning-Based Approach for the Diagnosis of Acute Lymphoblastic Leukemia

  2022cites this paper
• Surface Plasmon Resonance Immunosensor with Antibody-Functionalized Magnetoplasmonic Nanoparticles for Ultrasensitive Quantification of the CD5 Biomarker

  2022cites this paper
• Socio‐economic outcomes among long‐term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: Results of the 58LAE study

  2022cites this paper
• In-Silico and Biological Analysis of B-Cell Lymphoma-2 Gene and Genetic Mutation as Diagnostic Marker in Childhood Sudanese Acute Lymphoblastic Leukemia Patients, Gezira State, Sudan (2018)

  2022cites this paper
• Effects of splicing-regulatory polymorphisms in ABCC2, ABCG2, and ABCB1 on methotrexate exposure in Chinese children with acute lymphoblastic leukemia

  2022cites this paper
• Clinical Analysis of Childhood Acute Lymphoblastic Leukemia With Epilepsy Seizures

  2022cites this paper
• Next-Generation DNA Sequencing-Based Gene Panel for Diagnosis and Genetic Risk Stratification in Onco-Hematology

  2022cites this paper
• Microphysiological Drug‐Testing Platform for Identifying Responses to Prodrug Treatment in Primary Leukemia

  2022cites this paper
• Cellular senescence in cancers: relationship between bone marrow cancer and cellular senescence

  2022influential citation
• Molecular heterogeneity of β‐thalassemia variants in the Eastern region of Morocco

  2022influential citation
• A Nomogram for Predicting Event-Free Survival in Childhood Acute Lymphoblastic Leukemia: A Multicenter Retrospective Study

  2022cites this paper
• Clinical Implication of Toll-Like Receptors (TLR2 and TLR4) Polymorphisms in Adult Patients with Acute B-cell Lymphoblastic Leukemia

  2022cites this paper
• Technical Validation and Clinical Utility of an NGS Targeted Panel to Improve Molecular Characterization of Pediatric Acute Leukemia

  2022cites this paper
• Gut and liver involvement in pediatric hematolymphoid malignancies

  2022cites this paper
• Antibiotics in early life and childhood pre-B-ALL. Reasons to analyze a possible new piece in the puzzle

  2022cites this paper
• Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children

  2022cites this paper
• Cannabinoid drugs against chemotherapy-induced adverse effects: focus on nausea/vomiting, peripheral neuropathy and chemofog in animal models

  2022cites this paper
• Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases

  2022cites this paper
• Comparison of pulmonary toxicity after total body irradiation- and busulfan-based myeloablative conditioning for allogeneic hematopoietic stem cell transplantation for pediatric patients.

  2022cites this paper